Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial
Psilocybin-assisted psychotherapy appears feasible, acceptable, and safe in recently detoxified patients with comorbid alcohol use disorder and depression.
Authors
- Thibault Mura (ORCID: https://orcid.org/0000-0001-6420-1336)
- F. Sergent
- Carlos Graux (ORCID: https://orcid.org/0000-0001-9236-3623)
- Chris Serrand (ORCID: https://orcid.org/0000-0002-6074-8577)
- Amandine Luquiens (ORCID: https://orcid.org/0000-0002-9402-442X)
- Dahbia Belahda
- Noe Igounenc
- Paul Rochefort
Institutions
- Inserm (FR)
- Université de Versailles Saint-Quentin-en-Yvelines (FR)
- Université Paris-Saclay (FR)
- Centre de recherche en Epidémiologie et Santé des Populations (FR)
- Université de Nîmes (FR)
Publication Details
- Journal
- Addiction
- Published
- 2025-07-24
- DOI
- https://doi.org/10.1111/add.70152
- Citations
- 4
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 9.23